Genetic Analysis of Bordetella pertussis Isolates from the 2008-2010 Pertussis Epidemic in Japan

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Miyaji, Yusuke ^a,b   Otsuka, Nao ^a   Toyoizumi Ajisaka, Hiromi ^a   Shibayama, Keigo ^a   Kamachi, Kazunari ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BORDETELLA PERTUSSIS; CONTROLLED STUDY; DNA SEQUENCE; EPIDEMIC; FIM3 GENE; FIM3B GENE; GENE FREQUENCY; GENE SEQUENCE; GENETIC ANALYSIS; GEOGRAPHIC DISTRIBUTION; JAPAN; NONHUMAN; PERTUSSIS; PHENOTYPE; PREVALENCE; PRN GENE; PRN2 GENE; PTXA GENE; PTXA1 GENE; PTXP GENE; PTXP3 GENE; SEROTYPE; VARIABLE NUMBER OF TANDEM REPEAT;

ALLELES; BORDETELLA PERTUSSIS; CLUSTER ANALYSIS; GENE FREQUENCY; GENES, BACTERIAL; GENETIC VARIATION; HISTORY, 21ST CENTURY; HUMANS; JAPAN; MULTILOCUS SEQUENCE TYPING; PHENOTYPE; PUBLIC HEALTH SURVEILLANCE; WHOOPING COUGH;

EID: 84885049901     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0077165     Document Type: Article

References (48)

1. Mattoo S, Cherry JD, (2005) Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 18: 326-382.
2. Cherry JD, (2012) Epidemic pertussis in 2012-the resurgence of a vaccine-preventable disease. N Engl J Med 367: 785-787.
3. Spokes PJ, Quinn HE, McAnulty JM, (2010) Review of the 2008-2009 pertussis epidemic in NSW: notifications and hospitalisations. N S W Public Health Bull 21: 167-173.
4. Fisman DN, Tang P, Hauck T, Richardson S, Drews SJ, et al. (2011) Pertussis resurgence in Toronto, Canada: a population-based study including test-incidence feedback modeling. BMC Public Health 11: 694.
5. Campbell P, McIntyre P, Quinn H, Hueston L, Gilbert GL, et al. (2012) Increased population prevalence of low pertussis toxin antibody levels in young children preceding a record pertussis epidemic in Australia. PLoS One 7: e35874.
6. de Greeff SC, de Melker HE, van Gageldonk PG, Schellekens JF, van der Klis FR, et al. (2010) Seroprevalence of pertussis in The Netherlands: evidence for increased circulation of Bordetella pertussis. PLoS One 5: e14183.
7. Han HJ, Kamachi K, Okada K, Toyoizumi-Ajisaka H, Sasaki Y, et al. (2008) Antigenic variation in Bordetella pertussis isolates recovered from adults and children in Japan. Vaccine 26: 1530-1534.
8. Hewlett EL, Edwards KM, (2005) Clinical practice. Pertussis-not just for kids. N Engl J Med 352: 1215-1222.
9. Klein NP, Bartlett J, Rowhani-Rahbar A, Fireman B, Baxter R, (2012) Waning protection after fifth dose of acellular pertussis vaccine in children. N Engl J Med 367: 1012-1019.
10. Kallonen T, He Q, (2009) Bordetella pertussis strain variation and evolution postvaccination. Expert Rev Vaccines 8: 863-875.
11. Mooi FR, van Oirschot H, Heuvelman K, van der Heide HG, Gaastra W, et al. (1998) Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution. Infect Immun 66: 670-675.
12. Shuel M, Jamieson FB, Tang P, Brown S, Farrell D, et al. (2013) Genetic analysis of Bordetella pertussis in Ontario, Canada reveals one predominant clone. Int J Infect Dis 17: e413-e417.
13. Schmidtke AJ, Boney KO, Martin SW, Skoff TH, Tondella ML, et al. (2012) Population diversity among Bordetella pertussis isolates, United States, 1935-2009. Emerg Infect Dis 18: 1248-1255.
14. van Gent M, Bart MJ, van der Heide HG, Heuvelman KJ, Mooi FR, (2012) Small mutations in Bordetella pertussis are associated with selective sweeps. PLoS One 7: e46407.
15. Advani A, Gustafsson L, Åhrén C, Mooi FR, Hallander HO, (2011) Appearance of Fim3 and ptxP3-Bordetella pertussis strains, in two regions of Sweden with different vaccination programs. Vaccine 29: 3438-3442.
16. Petersen RF, Dalby T, Dragsted DM, Mooi F, Lambertsen L, (2012) Temporal trends in Bordetella pertussis populations, Denmark, 1949-2010. Emerg Infect Dis 18: 767-774.
17. Zhang L, Xu Y, Zhao J, Kallonen T, Cui S, et al. (2010) Effect of vaccination on Bordetella pertussis strains, China. Emerg Infect Dis 16: 1695-1701.
18. Mooi FR, van Loo IH, van Gent M, He Q, Bart MJ, et al. (2009) Bordetella pertussis strains with increased toxin production associated with pertussis resurgence. Emerg Infect Dis 15: 1206-1213.
19. Williamson P, Matthews R, (1996) Epitope mapping the Fim2 and Fim3 proteins of Bordetella pertussis with sera from patients infected with or vaccinated against whooping cough. FEMS Immunol Med Microbiol 13: 169-178.
20. Tsang RS, Lau AK, Sill ML, Halperin SA, Van Caeseele P, et al. (2004) Polymorphisms of the fimbria fim3 gene of Bordetella pertussis strains isolated in Canada. J Clin Microbiol 42: 5364-5367.
21. Kurniawan J, Maharjan RP, Chan WF, Reeves PR, Sintchenko V, et al. (2010) Bordetella pertussis clones identified by multilocus variable-number tandem-repeat analysis. Emerg Infect Dis 16: 297-300.
22. Octavia S, Sintchenko V, Gilbert GL, Lawrence A, Keil AD, et al. (2012) Newly emerging clones of Bordetella pertussis carrying prn2 and ptxP3 alleles implicated in Australian pertussis epidemic in 2008-2010. J Infect Dis 205: 1220-1224.
23. Litt DJ, Neal SE, Fry NK, (2009) Changes in genetic diversity of the Bordetella pertussis population in the United Kingdom between 1920 and 2006 reflect vaccination coverage and emergence of a single dominant clonal type. J Clin Microbiol 47: 680-688.
24. van Gent M, de Greeff SC, van der Heide HG, Mooi FR, (2009) An investigation into the cause of the 1983 whooping cough epidemic in the Netherlands. Vaccine 27: 1898-1903.
25. Lin YC, Yao SM, Yan JJ, Chen YY, Hsiao MJ, et al. (2006) Molecular epidemiology of Bordetella pertussis in Taiwan, 1993-2004: suggests one possible explanation for the outbreak of pertussis in 1997. Microbes Infect 8: 2082-2087.
26. Bisgard KM, Christie CD, Reising SF, Sanden GN, Cassiday PK, et al. (2001) Molecular epidemiology of Bordetella pertussis by pulsed-field gel electrophoresis profile: Cincinnati, 1989-1996. J Infect Dis 183: 1360-1367.
27. Queenan AM, Cassiday PK, Evangelista A, (2013) Pertactin-negative variants of Bordetella pertussis in the United States. N Engl J Med 368: 583-584.
28. Otsuka N, Han HJ, Toyoizumi-Ajisaka H, Nakamura Y, Arakawa Y, et al. (2012) Prevalence and genetic characterization of pertactin-deficient Bordetella pertussis in Japan. PLoS One 7: e31985.
29. Hegerle N, Paris AS, Brun D, Dore G, Njamkepo E, et al. (2012) Evolution of French Bordetella pertussis and Bordetella parapertussis isolates: increase of Bordetellae not expressing pertactin. Clin Microbiol Infect 18: E340-346.
30. Barkoff AM, Mertsola J, Guillot S, Guiso N, Berbers G, et al. (2012) Appearance of Bordetella pertussis strains not expressing the vaccine antigen pertactin in Finland. Clin Vaccine Immunol 19: 1703-1704.
31. Aoyama T, Murase Y, Iwata T, Imaizumi A, Suzuki Y, et al. (1986) Comparison of blood-free medium (cyclodextrin solid medium) with Bordet-Gengou medium for clinical isolation of Bordetella pertussis. J Clin Microbiol 23: 1046-1048.
32. van Loo IH, Heuvelman KJ, King AJ, Mooi FR, (2002) Multilocus sequence typing of Bordetella pertussis based on surface protein genes. J Clin Microbiol 40: 1994-2001.
33. Nakamura Y, Kamachi K, Toyoizumi-Ajisaka H, Otsuka N, Saito R, et al. (2011) Marked difference between adults and children in Bordetella pertussis DNA load in nasopharyngeal swabs. Clin Microbiol Infect 17: 365-370.
34. Tsang RS, Sill ML, Advani A, Xing D, Newland P, et al. (2005) Use of monoclonal antibodies to serotype Bordetella pertussis isolates: comparison of results obtained by indirect whole-cell enzyme-linked immunosorbent assay and bacterial microagglutination methods. J Clin Microbiol 43: 2449-2451.
35. Heikkinen E, Xing DK, Ölander RM, Hytönen J, Viljanen MK, et al. (2008) Bordetella pertussis isolates in Finland: serotype and fimbrial expression. BMC Microbiol 8: 162.
36. Hunter PR, Gaston MA, (1988) Numerical index of the discriminatory ability of typing systems: an application of Simpson's index of diversity. J Clin Microbiol 26: 2465-2466.
37. Grundmann H, Hori S, Tanner G, (2001) Determining confidence intervals when measuring genetic diversity and the discriminatory abilities of typing methods for microorganisms. J Clin Microbiol 39: 4190-4192.
38. Geuijen CA, Willems RJ, Bongaerts M, Top J, Gielen H, et al. (1997) Role of the Bordetella pertussis minor fimbrial subunit, FimD, in colonization of the mouse respiratory tract. Infect Immun 65: 4222-4228.
39. Parkhill J, Sebaihia M, Preston A, Murphy LD, Thomson N, et al. (2003) Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Nat Genet 35: 32-40.
40. Zhang S, Xu Y, Zhou Z, Wang S, Yang R, et al. (2011) Complete genome sequence of Bordetella pertussis CS, a Chinese pertussis vaccine strain. J Bacteriol 193: 4017-4018.
41. Alexander F, Matheson M, Fry NK, Labram B, Gorringe AR, (2012) Antibody responses to individual Bordetella pertussis fimbrial antigen Fim2 or Fim3 following immunization with the five-component acellular pertussis vaccine or to pertussis disease. Clin Vaccine Immunol 19: 1776-1783.
42. Guerry P, Ewing CP, Schirm M, Lorenzo M, Kelly J, et al. (2006) Changes in flagellin glycosylation affect Campylobacter autoagglutination and virulence. Mol Microbiol 60: 299-311.
43. Ulett GC, Valle J, Beloin C, Sherlock O, Ghigo JM, et al. (2007) Functional analysis of antigen 43 in uropathogenic Escherichia coli reveals a role in long-term persistence in the urinary tract. Infect Immun 75: 3233-3244.
44. Chiang SL, Taylor RK, Koomey M, Mekalanos JJ, (1995) Single amino acid substitutions in the N-terminus of Vibrio cholerae TcpA affect colonization, autoagglutination, and serum resistance. Mol Microbiol 17: 1133-1142.
45. Laird WJ, Cavanaugh DC, (1980) Correlation of autoagglutination and virulence of yersiniae. J Clin Microbiol 11: 430-432.
46. Alamuri P, Löwer M, Hiss JA, Himpsl SD, Schneider G, et al. (2010) Adhesion, invasion, and agglutination mediated by two trimeric autotransporters in the human uropathogen Proteus mirabilis. Infect Immun 78: 4882-4894.
47. Okada K, Komiya T, Yamamoto A, Takahashi M, Kamachi K, et al. (2010) Safe and effective booster immunization using DTaP in teenagers. Vaccine 28: 7626-7633.
48. Poolman JT, Hallander HO, (2007) Acellular pertussis vaccines and the role of pertactin and fimbriae. Expert Rev Vaccines 6: 47-56.